Altogether, the increased levels of DCA in NASH patients likely contribute to sequential oxidative stress, p53 transcription, PIDD processing and caspase-2 activation, culminating, at least in part, in NF-κB/miR-21/PDCD4-depdendent cell death and toxicity. The gene discussed is PDCD4; the disease is metabolic dysfunction-associated steatohepatitis.